What does IDS stand for in regulatory practice?

• A. Investigational Drug Service
• B. International Drug Safety
• C. Institutional Data Surveillance
• D. Investigational Device System

Answer: (A)

In regulatory practice, IDS stands for Investigational Drug Service. This is the unit within an institution, often a hospital or academic medical center, that manages investigational drugs for clinical trials. The IDS handles regulatory compliance with FDA IND requirements, IRB approvals, storage and accountability of investigational medications, dispensing to enrolled subjects, and meticulous documentation of dosing and adverse events. This role ensures patient safety and helps ensure trials run according to protocol and governing rules. The other options don’t fit because they do not represent a recognized function in drug regulatory practice, and “Investigational Device System” would refer to devices rather than drugs.